Milton B. McColl , MD

CEO

Gauss Surgical
Cupertino, CA

Milton B. McColl, M.D., is the CEO of Gauss Surgical, Inc., an early stage medical device company developing a mobile platform for real-time monitoring of surgical blood loss. Dr. McColl joined the board of Gauss in the summer of 2011. At the time he had been working closely with the company's founders during the spring of 2011 while he was mentoring students during the 2011 Spring Stanford Biodesign course. Prior to Gauss, Dr. McColl was a Venture Partner with New Leaf Venture Partners (NLVP) where he focused on investing in medical device companies. While at NLVP, he served on the board of IlluminOss Medical, Inc. and Glumetrics, Inc. For four years he also served on the board of Interlace which was sold to Hologics in January 2011. Dr. McColl left NLVP in June of 2011. Prior to joining New Leaf, Dr. McColl was President of the Neurovascular Division of Boston Scientific Corporation (BSC). He initially joined BSC in 2001 following the acquisition of Embolic Protection, Inc (EPI) where he served as Vice President and General Manager for the Embolic Protection Franchise, part of the Interventional Cardiology division of BSC. Dr. McColl joined EPI in 2000, as one of their first employees and as the Vice President of Clinical, Regulatory and Quality Affairs and Chief Medical Officer. Previously, he was the President and CEO of Genitope, Inc. an early stage biotechnology company focusing on patient-specific therapies for lymphoma which eventually became publicly traded; President and Chief Executive Officer of CSFluids, Inc. (later renamed Eunio), a development-stage company offering a surgical treatment for Alzheimer's Disease; Vice President of Regulatory Affairs, Quality Affairs, Clinical Affairs and Chief Medical Officer for Gynecare, Inc. (acquired by Johnson and Johnson) and Director of Marketing for Origin Medsystems (acquired by Eli Lilly/Guidant Corporation). Dr. McColl began his career as a professional football player with the San Francisco Forty-Niners and Los Angeles Raiders from 1981 to 1988. He was a member of two Super Bowl Championship teams for the Forty-Niners and was a special team's captain. Dr. McColl holds a B.S. in Biology from Stanford University and his M.D. from Stanford University School of Medicine. He currently sits on the boards of Compact Imaging and Gauss Surgical.